Jul 15, 2019 · We are a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary vaccine ...
Rating
(5)
Oncbiomune · Page · Biotechnology Company · (225) 227-2384 · oncbiomune.com · Rating · 4.2 (7 Reviews).
Sep 24, 2020 · "We are excited to officially complete our corporate name change to Theralink Technologies following the recent OncBioMune Pharmaceuticals' ...
People also ask
What are the 4 types of cancer vaccines?
What is immunotherapy for prostate cancer?
Does Keytruda treat prostate cancer?
What is the cancer injection treatment?
Sep 24, 2020 · OncBioMune Pharmaceuticals Inc. changed its name to Theralink Technologies Inc., effective Sept. 24. The name change follows the company's ...
ProscaVax is an immunotherapy candidate that OncBioMune Pharmaceuticals is developing as a treatment for prostate cancer.
OncBioMune Pharmaceuticals owns proprietary rights to a therapeutic vaccine for prostate cancer that can truly save lives! #cancer #immunotherapy #stocks ...
OncBioMune acquires assets of Avant Diagnostics - S&P Global
www.spglobal.com › latest-news-headlines
Jun 8, 2020 · OncBioMune Pharmaceuticals Inc. acquired all assets of privately held Avant Diagnostics Inc. Washington, D.C.-based Avant develops screening ...